REQUEST A DEMO
Total
USD $0.00
Search more companies

Demersan Biyoteknoloji Imalat A.S. (Turkiye)

Main Activities: Surgical and Medical Instrument Manufacturing
Full name: Demersan Biyoteknoloji Imalat Sanayi Ve Ticaret Anonim Sirketi Profile Updated: November 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Demersan Biyoteknoloji Imalat A.S. is an enterprise located in Turkiye, with the main office in Ankara. It operates in the Surgical and Medical Instrument Manufacturing sector. The company was established on June 09, 2010. There are currently 49 (2025) people employed by Demersan Biyoteknoloji Imalat A.S.. The latest financial highlights indicate a net sales revenue increase of 71.7% in 2023. A growth of 105% was recorded in its total assets. The net profit margin of Demersan Biyoteknoloji Imalat A.S. decreased by 3.95% in 2023.

Headquarters
No:92 Bati Sitesi Mahallesi Tahsin Kahraman Caddesi Yenimahalle
Ankara; Central Anatolia; Postal Code: 06370

Contact Details: Purchase the Demersan Biyoteknoloji Imalat A.S. report to view the information.

Website: http://www.demersan.com.tr

Basic Information
Total Employees:
Purchase the Demersan Biyoteknoloji Imalat A.S. report to view the information.
Financial Auditors:
Purchase the Demersan Biyoteknoloji Imalat A.S. report to view the information.
Incorporation Date:
June 09, 2010
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Demersan Biyoteknoloji Imalat A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
71.7%
Total operating revenue
71.7%
Operating profit (EBIT)
16.9%
Net Profit (Loss) for the Period
15.49%
Total assets
105%
Total equity
114.88%
Operating Profit Margin (ROS)
-5.08%
Net Profit Margin
-3.95%
Return on Equity (ROE)
-17.04%
Debt to Equity Ratio
2.76%
Quick Ratio
0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?